💊 Oral Wegovy is the first FDA-approved GLP-1 pill for weight loss. Approved December 2025. 💊 Oral Wegovy, FDA approved Dec 2025.
Home›Medications›Oral Wegovy
✓ FDA Approved 🆕 Dec 2025 GLP-1 · Novo Nordisk

Oral Wegovy

Oral Semaglutide · Approved December 2025

The first FDA-approved GLP-1 pill specifically for weight loss, delivering injection-level results in a once-daily tablet. Requires an empty stomach, but no needle required.

💊
Overview How It Works Results Who It's For Side Effects Cost Compare FAQ
At a Glance

Everything You Need to Know

Avg. Weight Loss
15%
Of starting body weight
Form & Schedule
Daily Pill
Once per day
Food Restriction
Required
Empty stomach, 30+ min before food
Active Ingredient
Semaglutide
Same as Wegovy injection
Manufacturer
Novo Nordisk
Same maker as Ozempic
FDA Status
✅ Approved
Approved December 2025
Plain English

What Exactly Is Oral Wegovy?

Same drug as injectable Wegovy. In pill form, no needles required.Oral Wegovy is the pill version of Wegovy, the injection that took the weight loss world by storm. Same active ingredient, same mechanism, same clinical results.

Oral Wegovy contains semaglutide, a peptide molecule. Because peptides break down when they contact food, it must be taken on a completely empty stomach with plain water, at least 30 minutes before your first food or drink of the day. This is the main trade-off compared to Foundayo. But for people who can stick to that routine, Oral Wegovy delivers the same 15% weight loss as the Wegovy injection, without the weekly needle.

It was approved in December 2025, making it the first GLP-1 pill to receive FDA approval specifically for weight management in adults.

The Science, Simply

How Oral Wegovy Works

Semaglutide mimics a hunger hormone your body already produces naturally.Semaglutide mimics a natural hunger hormone your body already makes after eating.

1

Mimics GLP-1

Semaglutide activates the same GLP-1 receptors your body uses to signal fullness after a satisfying meal. This reduces hunger throughout the day, not just after eating.

2

Slows Gastric Emptying

Food moves more slowly out of your stomach, keeping you full longer after each meal. This naturally reduces how much you eat without requiring willpower or calorie counting.

3

Quiets Food Noise

GLP-1 receptors in the brain's reward center reduce cravings for high-calorie foods. Most patients report the constant mental preoccupation with food diminishes significantly within the first few weeks.

Clinical Trial Data

What the Trials Showed

From the OASIS 4 trial: 64 weeks, adults with obesity or overweight.Oral Wegovy was approved based on the OASIS 4 trial, a 64-week study of adults with obesity or overweight.

15%
Average Body Weight Lost
16.6% in adherent patients at 64 weeks
34%
Lost 20%+ of Body Weight
vs. 2.9% on placebo
70%+
Prediabetes Reversed
Blood glucose normalized in prediabetic participants
ℹ️ Individual results vary. Trial participants followed a reduced-calorie diet and increased physical activity. Results are strongest in patients who take the medication consistently with proper fasting protocol.

"Some of my patients just don't want to deal with a weekly injection. Not afraid of needles, just don't want it as part of their routine. Oral semaglutide at this dose is the first time I've had a real answer for that."

Dr. Quoc N. Dang, DO

Dr. Quoc N. Dang, DO

Bariatric Surgeon · Obesity Medicine

Eligibility

Is Oral Wegovy Right for You?

Prescription only. A morning fasting routine is required.Oral Wegovy requires a prescription and a commitment to morning fasting protocol.

✅ Good Candidates

  • BMI of 30 or higher
  • BMI of 27+ with a weight-related condition
  • People who want injection-level results without needles
  • Those who can reliably take a pill first thing in the morning before eating
  • Adults who prefer a pill over weekly injections

⚠️ May Not Be Right If...

  • You have an irregular morning schedule or frequently skip breakfast
  • You have a personal or family history of thyroid cancer (MTC)
  • You have Multiple Endocrine Neoplasia syndrome type 2
  • You're pregnant or breastfeeding
  • You have a history of pancreatitis

⚕️ Always consult your doctor before starting any weight loss medication.

What to Expect

Side Effects

Mostly mild and short lived. Things typically settle within 4 to 8 weeks.Side effects are most common in the first 4 to 8 weeks and typically improve as your body adjusts to the medication.

Common Side Effects

Usually mild · Often improve over time
  • Nausea25%
  • Diarrhea15%
  • Vomiting10%
  • Constipation9%
  • Decreased appetite12%
  • Stomach discomfort8%

Serious (Rare) Side Effects

Uncommon · Contact your doctor immediately
  • Severe abdominal pain (possible pancreatitis)
  • Rapid heart rate
  • Kidney problems (from dehydration)
  • Gallbladder disease
  • Severe allergic reaction
Pricing & Access

What Does Oral Wegovy Cost?

One of the most affordable branded GLP-1 options at launch.Oral Wegovy launched with competitive self-pay pricing, making it one of the most affordable branded GLP-1 options.

Self-Pay (Starting Dose)

$149/mo
Through NovoCare Pharmacy for the 1.5 mg starting dose. One of the most affordable GLP-1 options.

With Commercial Insurance

As low as $25/mo
Novo Nordisk savings offer for eligible commercially insured patients.

Self-Pay (Maintenance)

$299/mo
For higher maintenance doses via NovoCare Pharmacy with free home delivery.
💡 Tip: Oral Wegovy is available through NovoCare Pharmacy with free home delivery. The $149/month starting price makes it one of the most accessible branded GLP-1 weight loss medications available.
Side by Side

Oral Wegovy vs. Other Options

Oral Wegovy vs. the other leading weight loss medications.See how Oral Wegovy compares to the other leading weight loss medications.

MedicationAvg. Weight LossFormFood RestrictionApproved For
💊Oral Wegovy You're here 15% Daily Pill Empty stomach Weight Loss
💊Foundayo 12.4% Daily Pill None ✓ Weight Loss
💉Zepbound 21% Weekly Injection None ✓ Weight Loss
💉Wegovy 15% Weekly Injection None ✓ Weight Loss
Common Questions

Frequently Asked Questions

If you eat before taking Oral Wegovy, the food in your stomach breaks down the semaglutide peptide, significantly reducing how much gets absorbed into your bloodstream. This means less of the medication works, and your weight loss results will be reduced. Consistency with the fasting protocol is critical for this medication to work properly.
Both are oral semaglutide pills from Novo Nordisk and both require an empty stomach. The key differences are dose and purpose. Rybelsus is approved for Type 2 diabetes at 7 mg and 14 mg doses. Oral Wegovy is specifically approved for weight loss at higher doses, starting at 1.5 mg and going up to 25 mg, which is why it produces significantly more weight loss.
Most people notice reduced appetite within the first 2 to 4 weeks. Visible weight loss typically begins between weeks 4 and 8, with the most significant results occurring between weeks 16 and 64. The medication uses a dose escalation schedule, starting low to minimize side effects and gradually increasing to your maintenance dose.
No. Oral Wegovy and Ozempic contain the same active ingredient, semaglutide. Taking both simultaneously would be a dangerous overdose. If you are currently on Ozempic and want to switch to Oral Wegovy, talk to your doctor about the appropriate transition plan.
Clinical data shows most people regain a significant portion of lost weight within 12 months of stopping any GLP-1 medication. Many doctors view these as long-term treatments. Discuss a maintenance plan with your doctor before starting.
Dr. Quoc N. Dang, DO
Medically Reviewed by
Dr. Quoc N. Dang, DO
Bariatric Surgeon
Keep Exploring

Other Medications to Consider

💊
Foundayo
GLP-1 Pill · Eli Lilly
No food restrictions
💉
Zepbound
GLP-1/GIP Injection · Eli Lilly
21% weight loss
💉
Wegovy
GLP-1 Injection · Novo Nordisk
15% weight loss
View All Medications →